Different Treatment Modalities for Atrophied Distal Extension Maxillary Ridges

February 27, 2022 updated by: Mansoura University

Comparison Between Three Different Treatment Modalities for Atrophied Distal Extension Maxillary Ridges Clinical and Radiographic Study

This study will compare clinical and radiographic outcomes of three different treatment modalities for atrophied distal extension maxillary ridges these modalities include

  1. Implant retained distal extension RPD
  2. Sinus lift and long implant and screw-retained prosthesis
  3. Short implant and screw-retained prosthesis

Study Overview

Detailed Description

Patient selection:

For this study, 60 patients were selected from the clinic of Prosthodontic Department, Faculty of Dentistry, Mansoura University.

Inclusion criteria:

The patients will be selected according to the following:

  • They have distal extension maxillary ridge with sinus pneumatization and remaining alveolar bone height 6- 8mm as verified by preoperative CBCT, have no previous denture experience. They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory investigations.
  • Posterior maxillary alveolar ridge deficient in height, width and covered with healthy firm mucosa.
  • Patients are less satisfied with conventional RPD.
  • Absence of maxillary sinus diseases. Exclusion criteria

Patients were not eligible for this work if any of the following criteria were met:

  • Acute or chronic sinus pathology
  • History of a sinus augmentation in the past in the relevant sinus
  • Poor dental hygiene. Smoker.
  • Compromised general health (uncontrolled diabetes, bleeding disorder….). All patient were informed about all procedures that will be done and they sign the written consent form of ethical committee in faculty of dentistry Mansoura university.

Three treatment groups will be classified randomly, as follow:

  • Group A: patients received two implant in premolar area mesial to maxillary sinus and used to retain partial overdenture
  • Group B: patient underwent sinus lift and receive screw retained prosthesis on long implant
  • Group C: patients received short implants in premolar area mesial to maxillary sinus and received screw retained prothesis All implants were inserted using computer guided implant surgery and conventional loading protocol was used.

Evaluation methods Clinical and radiographic evaluation

  1. Modified Plaque index. Assessment of plaque accumulation with a modified plaque index (mPI): Score 0: No detection of plaque, Score 1: Plaque only recognized by running a probe across the smooth marginal surface of the implant, Score 2 Plaque can be seen by a naked eye, Score 3 Abundance of soft matter.
  2. Gingival index. Assessment of bleeding tendency with a modified sulcus bleeding index (mBI): Score 0 No bleeding when a periodontal probe is passed along the gingival margin adjacent to the implant. Score 1 Isolated bleeding spot visible, Score 2 Blood forms a confluent red line on margin, Score 3 Heavy or profuse bleeding.
  3. Attachment level. Distance from the junction implant/crown to the most apically probeable portion, in millimeters.
  4. Pocket depth. Distance between the gingival margin and the most apically probable portion, in millimeters Assessed by insertion of a standard periodontal probe with a point diameter of 0.5 mm using a probing force of 0.5 N.
  5. Implant stability quotient. Using resonance frequency analysis

    b- Radiographic evaluation will be performed in terms of:

    Vertical bone loss (VBL) will be evaluated as follows:

    The distance between implant plate form and first bone to implant contact (DIM) will be evaluated at T0, T6 and T12. VBL will be calculated by subtracting DIM at T6 and T12 from DIM at T0.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Eldakahlia
      • Mansoura, Eldakahlia, Egypt, 35516
        • Faculty of Dentistry, Mansoura University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

The patients will be selected according to the following:

  • They have distal extension maxillary ridge with sinus pneumatization and remaining alveolar bone height 6- 8mm as verified by preoperative CBCT, have no previous denture experience. They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory investigations.
  • Posterior maxillary alveolar ridge deficient in height, width and covered with healthy firm mucosa.
  • Patients are less satisfied with conventional RPD.
  • Absence of maxillary sinus diseases.

Exclusion Criteria:

  • Acute or chronic sinus pathology
  • History of a sinus augmentation in the past in the relevant sinus
  • Poor dental hygiene. Smoker.
  • Compromised general health (uncontrolled diabetes, bleeding disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: overdentures
implant overdentures
insertion of long implants anterior to the maxillary sinus to retain partial overdentures
Distal extension metallic partial dentures retained by attachments to the implants
ACTIVE_COMPARATOR: sinus lift
sinus lift and long implants and screw-retained prosthesis
performing sinus lift surgical procedure with simultaneous placement of long implants to support screw-retained prosthesis
porcelain fused to metal fixed screw-retained prosthesis supported by long implants
ACTIVE_COMPARATOR: short implants
short implants and screw-retained prosthesis
placement of short implants in the remaining bone above maxillary sinus to support screw-retained prosthesis without performing sinus lift
porcelain fused to metal fixed screw-retained prosthesis supported by short implants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plaque index
Time Frame: one year
measuring plaque accumulation around implants using scores
one year
Gingival index
Time Frame: one year
measuring gingival inflammation around implants using scores
one year
Probing depth
Time Frame: one year
measuring peri-implant probing depth in mm
one year
implant stability
Time Frame: one year
measuring the mobility of the implants using resonance frequency analysis Implant stability quotient)
one year
Marginal bone loss
Time Frame: one year
measuring crestal bone loss around implants in mm
one year
Patient satisfaction using VAS questionnaire (visual analogue scale)
Time Frame: one year
Regarding VAS, participants were asked to score their answer according to the amount of satisfaction on a 100mm line (Score zero = no satisfaction at all and score 100 = complete satisfaction). The questions cover several items related to prosthesis such as: retention, stability, comfort, ease of cleaning, ease of speaking, ease of chewing, limited activities due to embarrassment, quality of bolus and appearance.
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
maximum bite force
Time Frame: one year
measuring maximum bite force in newton using bite force transducers
one year
Prosthetic Aspects
Time Frame: one year
measuring the incidence of prosthetic aspects and maintenance requirements
one year
Muscle activity
Time Frame: one year
measure muscles activity in amplitude using electromyographs
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2020

Primary Completion (ACTUAL)

May 1, 2021

Study Completion (ANTICIPATED)

June 1, 2022

Study Registration Dates

First Submitted

September 24, 2021

First Submitted That Met QC Criteria

January 6, 2022

First Posted (ACTUAL)

January 20, 2022

Study Record Updates

Last Update Posted (ACTUAL)

March 2, 2022

Last Update Submitted That Met QC Criteria

February 27, 2022

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • M06030320

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe